Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psychosis, Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02535923
What this trial is testing

CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes

Who this might be right for
InsomniaPsychosis
VA Office of Research and Development 47
Early research (Phase 1)Study completedNCT00937846
What this trial is testing

Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study

Who this might be right for
Cognitive Disorders
GlaxoSmithKline 4
Post-approval studies (Phase 4)UnknownNCT00937261
What this trial is testing

Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning

Who this might be right for
Schizophrenia
University of California, Irvine 96
Not applicableStudy completedNCT03037983
What this trial is testing

Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic Stimulation

Who this might be right for
SchizophreniaSchizoaffective Disorder
VA Office of Research and Development 9
Early research (Phase 1)Study completedNCT06315283
What this trial is testing

An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Teva Branded Pharmaceutical Products R&D LLC 153
Not applicableUnknownNCT02932059
What this trial is testing

Evaluation of Metamemory Using a Semantic Construction Strategy in Patients With Schizophrenia

Who this might be right for
SchizophreniaAging
University Hospital, Clermont-Ferrand 120
Not applicableLooking for participantsNCT06687694
What this trial is testing

Immune Mechanisms of Antipsychotic Treatment Response

Who this might be right for
Psychosis
King's College London 500
Not applicableStudy completedNCT02594696
What this trial is testing

Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness

Who this might be right for
Major DepressionSchizophreniaBipolar Disorder+5 more
Massachusetts General Hospital 30
Post-approval studies (Phase 4)Study completedNCT06041646
What this trial is testing

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

Who this might be right for
Bipolar DisorderSchizophreniaAgitation,Psychomotor+2 more
BioXcel Therapeutics Inc 29
Not applicableStudy completedNCT03288779
What this trial is testing

Theta Burst Stimulation for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Duke University 6
Not applicableStudy completedNCT04221269
What this trial is testing

Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders

Who this might be right for
SchizophreniaSuicide
Butler Hospital 30
Early research (Phase 1)Study completedNCT00690170
What this trial is testing

Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy Subjects

Who this might be right for
Healthy Subjects
Yale University 30
Not applicableStudy completedNCT05473741
What this trial is testing

Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

Who this might be right for
SchizophreniaSchizophrenia Relapse
Centre for Addiction and Mental Health 51
Not applicableEnded earlyNCT02841956
What this trial is testing

Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement

Who this might be right for
Psychotic Disorders
University of California, Davis 427
Post-approval studies (Phase 4)Study completedNCT03304457
What this trial is testing

Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia

Who this might be right for
Schizophrenia
All India Institute of Medical Sciences, Bhubaneswar 100
Not applicableEnrolling By InvitationNCT03970005
What this trial is testing

Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis

Who this might be right for
Prodromal Schizophrenia
Ohio State University 100
Post-approval studies (Phase 4)Study completedNCT00565175
What this trial is testing

Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia

Who this might be right for
Schizophrenia
Jesper Ekelund 30
Early research (Phase 1)Study completedNCT00795730
What this trial is testing

Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789

Who this might be right for
Alzheimer DiseaseHealthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer 24
Large-scale testing (Phase 3)Study completedNCT02694328
What this trial is testing

ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)

Who this might be right for
Schizophrenia
Alkermes, Inc. 561
Not applicableEnded earlyNCT00209027
What this trial is testing

The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia

Who this might be right for
Schizophrenia
Emory University 20
Next Page